Iovance Biotherapeutics Inc. Common Stock vs TTM Technologies Inc. Common Stock — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.6 (market cap $6.04B), while TTM Technologies Inc. Common Stock trades at $121 (market cap $12.38B). The key difference: TTM Technologies Inc. Common Stock is far larger — about 2× Iovance Biotherapeutics Inc. Common Stock's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, TTM Technologies Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and TTM Technologies Inc. Common Stock for 0 Days on average.
| IOVA | TTMI | |
|---|---|---|
Market Cap | $6.04B | $12.38B |
Volume | 14,805,993 | 2,258,598 |
Sector | Health | Technology |
52-Week High | $14.82 | $221.47 |
52-Week Low | $1.81 | $53.58 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.97B | $12.97B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →TTM Technologies manufactures printed circuit boards, radio-frequency components, and electronics assemblies. Its products are used in aerospace, defense, automotive, data center, and communications equipment.
Read more on TTMI →